Amy Elizabeth Farrell, MD | |
106 W John Rowan Blvd Ste E, Bardstown, KY 40004-2636 | |
(502) 894-9494 | |
(502) 894-9404 |
Full Name | Amy Elizabeth Farrell |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 22 Years |
Location | 106 W John Rowan Blvd Ste E, Bardstown, Kentucky |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356372759 | NPI | - | NPPES |
NOO72D | Medicaid | SC | |
7100087230 | Medicaid | KY | |
5909940 | Medicaid | NC |
Facility Name | Location | Facility Type |
---|---|---|
Norton Hospitals, Inc | Louisville, KY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Community Medical Associates Inc | 7012811284 | 1097 |
News Archive
The January 3 issue of the New England Journal of Medicine "includes the first article in a series of review articles on global health," Harvey Fineberg of the Institute of Medicine and David Hunter of the Harvard School of Public Health write in an NEJM editorial.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).
A large randomized controlled, pragmatic trial involving 1445 patients with allergic asthma found that an integrative medicine approach in which acupuncture is added to routine care demonstrated improvements in both quality of life and physical and mental health for those receiving acupuncture.
› Verified 2 days ago
Entity Name | Community Medical Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588614994 PECOS PAC ID: 7012811284 Enrollment ID: O20031120000656 |
News Archive
The January 3 issue of the New England Journal of Medicine "includes the first article in a series of review articles on global health," Harvey Fineberg of the Institute of Medicine and David Hunter of the Harvard School of Public Health write in an NEJM editorial.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).
A large randomized controlled, pragmatic trial involving 1445 patients with allergic asthma found that an integrative medicine approach in which acupuncture is added to routine care demonstrated improvements in both quality of life and physical and mental health for those receiving acupuncture.
› Verified 2 days ago
Entity Name | Obhg Kentucky Psc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457644122 PECOS PAC ID: 5496910200 Enrollment ID: O20120628000666 |
News Archive
The January 3 issue of the New England Journal of Medicine "includes the first article in a series of review articles on global health," Harvey Fineberg of the Institute of Medicine and David Hunter of the Harvard School of Public Health write in an NEJM editorial.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).
A large randomized controlled, pragmatic trial involving 1445 patients with allergic asthma found that an integrative medicine approach in which acupuncture is added to routine care demonstrated improvements in both quality of life and physical and mental health for those receiving acupuncture.
› Verified 2 days ago
Entity Name | Kentucky Ob Hospitalist Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013548973 PECOS PAC ID: 0446679831 Enrollment ID: O20201005001540 |
News Archive
The January 3 issue of the New England Journal of Medicine "includes the first article in a series of review articles on global health," Harvey Fineberg of the Institute of Medicine and David Hunter of the Harvard School of Public Health write in an NEJM editorial.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).
A large randomized controlled, pragmatic trial involving 1445 patients with allergic asthma found that an integrative medicine approach in which acupuncture is added to routine care demonstrated improvements in both quality of life and physical and mental health for those receiving acupuncture.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Amy Elizabeth Farrell, MD Po Box 780982, Philadelphia, PA 19178-0982 Ph: (303) 306-7783 | Amy Elizabeth Farrell, MD 106 W John Rowan Blvd Ste E, Bardstown, KY 40004-2636 Ph: (502) 894-9494 |
News Archive
The January 3 issue of the New England Journal of Medicine "includes the first article in a series of review articles on global health," Harvey Fineberg of the Institute of Medicine and David Hunter of the Harvard School of Public Health write in an NEJM editorial.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).
A large randomized controlled, pragmatic trial involving 1445 patients with allergic asthma found that an integrative medicine approach in which acupuncture is added to routine care demonstrated improvements in both quality of life and physical and mental health for those receiving acupuncture.
› Verified 2 days ago
Dr. James T Dodge, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 919b Chambers Blvd, Bardstown, KY 40004 Phone: 502-349-1411 Fax: 502-349-0980 | |
Dr. Basim Kahleifeh, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 118 Patriot Drive, Suite 202, Bardstown, KY 40004 Phone: 502-348-8100 Fax: 502-348-8900 | |
Carmen Yvette Young Folmar, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4359 New Shepherdsville Rd, Suite 255, Bardstown, KY 40004 Phone: 502-350-5800 Fax: 502-350-5820 | |
Hanna V. Peterson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4359 New Shepherdsville Rd Unit 255, Bardstown, KY 40004 Phone: 502-350-5800 Fax: 502-350-5820 | |
Dr. Hannah Morgan Hall, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4359 New Shepherdsville Rd, Ste 255, Bardstown, KY 40004 Phone: 502-350-5800 Fax: 502-350-5820 |